Olopatadine Hydrochloride Ophthalmic Solution 82442-0967-02
- Manufacturer
- Target Corporation
- Dosage Form
- Solution
- Route
- Ophthalmic
- Product Type
- Human Otc Drug
- Marketing Start
- April 15, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA206087
Active Ingredients
| Ingredient | Strength |
|---|---|
| Olopatadine Hydrochloride | 2 mg/mL |
Drug Class
Decreased Histamine Release [PE]Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Selected Package
82442-0967-02Selected1 BOTTLE, PLASTIC in 1 CARTON (82442-967-02) / 3.5 mL in 1 BOTTLE, PLASTIC